In this scenario, by providing cancer cells with a clear growth advantage by activating this signaling network and enabling efficient proliferation and suppression of growth-arresting pathways, the MYC–PLK1 interaction could play a critical role in tumor initiation. The gene discussed is PLK1; the disease is neoplasm.